Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Mann

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
BMJ (Clinical Research Ed.)|April 28, 2000
Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practiceR D Mann, G L Pearce, N Dunn, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Did knowledge, opinions, background, and health authority advice influence early prescribing of the novel Alzheimer's disease drug donepezil in general practice?--national postal surveyR M Martin, E Rink, D G Wilkinson, et al.
Pharmacoepidemiology and Drug Safety|July 1, 1997
Myocardial infarction and oral contraceptives, a retrospective case control study in England and Scotland ('MICA' Study)N R Dunn, M Thorogood, L de Caestecker, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Is the incidence of upper respiratory tract infection independent of drug treatment in large cohort studies of longer term use drugs?L V Wilton, S N Freemantle, R Martin, et al.
BJU International|February 26, 2000
The pharmacovigilance of tamsulosin: event data on 12484 patientsR D Mann, P Biswas, S Freemantle, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Safety profile of nicorandil--prescription-event monitoring (PEM) studyN Dunn, S Freemantle, G Pearce, et al.
BMJ (Clinical Research Ed.)|July 10, 1998
Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational studyR M Martin, K V Kapoor, L V Wilton, et al.
Lancet (London, England)|March 31, 1998
Galactorrhoea with moclobemideN R Dunn, S N Freemantle, G L Pearce, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Nefazodone in community use: the results of prescription-event monitoringF J Mackay, G L Pearce, S N Freemantle, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1995
Signalling drug-induced rash with 36 drugs recently marketed in the United Kingdom and studied by Prescription-Event MonitoringK Kubota, N Kubota, G L Pearce, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
BMJ (Clinical Research Ed.)|April 28, 2000
Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practiceR D Mann, G L Pearce, N Dunn, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Did knowledge, opinions, background, and health authority advice influence early prescribing of the novel Alzheimer's disease drug donepezil in general practice?--national postal surveyR M Martin, E Rink, D G Wilkinson, et al.
Pharmacoepidemiology and Drug Safety|July 1, 1997
Myocardial infarction and oral contraceptives, a retrospective case control study in England and Scotland ('MICA' Study)N R Dunn, M Thorogood, L de Caestecker, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Is the incidence of upper respiratory tract infection independent of drug treatment in large cohort studies of longer term use drugs?L V Wilton, S N Freemantle, R Martin, et al.
BJU International|February 26, 2000
The pharmacovigilance of tamsulosin: event data on 12484 patientsR D Mann, P Biswas, S Freemantle, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Safety profile of nicorandil--prescription-event monitoring (PEM) studyN Dunn, S Freemantle, G Pearce, et al.
BMJ (Clinical Research Ed.)|July 10, 1998
Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational studyR M Martin, K V Kapoor, L V Wilton, et al.
Lancet (London, England)|March 31, 1998
Galactorrhoea with moclobemideN R Dunn, S N Freemantle, G L Pearce, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Nefazodone in community use: the results of prescription-event monitoringF J Mackay, G L Pearce, S N Freemantle, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1995
Signalling drug-induced rash with 36 drugs recently marketed in the United Kingdom and studied by Prescription-Event MonitoringK Kubota, N Kubota, G L Pearce, et al.
Pageof 8